Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Cancer. 2018 Nov 5;124(23):4548–4555. doi: 10.1002/cncr.31725

Table IV.

Axitinib pharmacokinetic (PK) parameters (median (range))

Pharmacokinetic Parameter Dose Level 2.4 mg/m2 Dose Level 3.2 mg/m2
Day 1 (n=12) Day 8 (n=12) Day 1 (n=6) Day 8 (n=5)
Tmax (h) 2.0 (1.0–4.0) 1.5 (0–4.0) 2.0 (1.0–4.0) 2.0 (1.1–4.0)
Cmax (ng/mL) 23.8 (2.5–55.6) 47.4 (4.5–92.6) 38.0 (16.3–58.1) 41.5 (15.5–76.5)
Half life (h) 2.2 (0.7–5.2) 2.5 (0.9–631.5) 2.6 (1.1–3.2) 1.8 (1.1–4.3)
AUC0–8h (h•ng/mL) 91.0 (10.7–264.1) 146.7 (8.9–372.7) 134.3 (59.0–236.0) 139.9 (54.9–349.1)
Accumulation (AUC Day8/Day1) 1.7 (0.3–4.7) 1.8 (0.4–2.5)
Cl/F (L/h) 28.0 (9.8–230.1) 32.6 (14.2–65.2)
Cl/m2 (L/h/m2) 21.4 (6.0–230.1) 19.9 (11.4–61.5)
V/F (L) 74.9 (43.6–888.7) 99.4 (48.9–150.6)
V/m2 (L/m2) 67.4 (39.1–888.7) 65.5 (39.1–101.6)